Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hexvix fluorescence cystoscopy versus white light cystoscopy in detection and early recurrence of papillary bladder cancer
2004-002259-15Phase 3Completed
- Sponsor
- Photocure
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hexaminolevulinate in bladder cancer (2 arms), sponsored by Photocure. Primary endpoints: Detection rate of histologically confirmed bladder lesions and Early recurrence rate of bladder cancer. Started Dec 2004; status: completed.
02
Drugs
hexaminolevulinate
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2004-002259-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002259-15.